Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen ...

Among more than 5,000 patients followed for a median of roughly 8 years, bilateral risk-reducing mastectomy (RRM) was ...

Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), in partnership with the American Association for Cancer Research (AACR), is hosting the 47th ...

Detections of ctDNA at baseline in patients with HR-positive early breast cancer were associated with larger tumor size.

Icad (NASDAQ: ICAD) Presents Four AI-Driven Breast Cancer Research Abstracts at the 2024 San Antonio Breast Cancer Symposium ...

Presentations include analytical validation of Myriad’s high-definition tumor informed MRD assay for breast cancer and its ...

Meta-analysis of three trials found that immediate breast surgery in women over 70 cut breast cancer death rates in half ...

Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent ...

Imlunestrant, a next-generation SERD, improves progression-free survival in ER-positive advanced breast cancer patients ...

Palazestrant, in combination with ribociclib, demonstrated promising clinical activity, a safety profile consistent with ribociclib and endocrine ...

For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced ...